MYSZ.NASDAQMy Size, INC

DEF 14A: My Size, Inc. Announces Annual Meeting of Stockholders to be Held on December 30, 2024

Sentiment:

Proxy Statement


My Size, Inc. will hold its annual meeting of stockholders on December 30, 2024, to elect a director and ratify the appointment of its independent public accountant.

Summary

  • My Size, Inc. will hold its Annual Meeting of Stockholders on December 30, 2024, at 10:00 a.m. (local time) at the offices of Barnea Jaffa Lande & Co Law Offices in Tel Aviv, Israel.
  • Stockholders of record as of November 4, 2024, are entitled to vote at the meeting.
  • The meeting will address the election of Ronen Luzon as a Class III director for a three-year term and the ratification of Somekh Chaikin as the independent public accountant for the fiscal year ending December 31, 2024.
  • The Board of Directors recommends voting FOR the election of the director nominee and FOR the ratification of the accountant appointment.
  • Proxy materials are available online, and the company intends to begin sending notices to stockholders on or about November 4, 2024.
  • A quorum requires the presence of holders of one-third of the outstanding shares of common stock, which is 420,044 shares out of 1,260,131 shares outstanding as of the record date.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, so the sentiment is neutral to slightly positive due to the routine nature of the announcements and the board's recommendations.

Positives

  • The company is following good corporate governance practices by submitting the selection of the independent auditor to stockholders for ratification.
  • The board of directors has determined that each member of the audit committee is independent.
  • The company has a Code of Business Conduct and Ethics that applies to all employees.

Future Outlook

The document outlines the procedures and deadlines for stockholders to submit proposals for the 2025 Annual Meeting, indicating a continuation of corporate governance practices.

Management Comments

  • The Board of Directors recommends a vote FOR Proposals 1 and 2.
  • The board of directors believes the Company is well-served by this flexible leadership structure and that the combination or separation of these positions should continue to be considered on an ongoing basis.

Industry Context

This announcement is a standard part of corporate governance, ensuring shareholders have the opportunity to participate in key decisions such as electing directors and ratifying the appointment of auditors.

Comparison to Industry Standards

  • The structure of the board with staggered terms is a common practice among publicly traded companies to ensure continuity and experience.
  • The use of independent audit, compensation, and nominating committees aligns with best practices in corporate governance, similar to companies like Nike, Apple, and Microsoft.
  • The detailed disclosure of director compensation and security ownership is consistent with SEC regulations and industry standards, as seen in filings from companies like Tesla and Amazon.

Related Party Transactions

  • Ronen Luzon, the Chief Executive Officer and a member of the board of directors, and Billy Pardo, the Chief Product Officer and Chief Operating Officer, are husband and wife.

Stakeholder Impact

  • Shareholders have the opportunity to vote on key company decisions.
  • Employees are indirectly affected by the election of directors and the ratification of the auditor.
  • The outcome of the votes can influence investor confidence and the company's future direction.

Next Steps

  • Stockholders should review the proxy materials and vote on the proposals.
  • The company will hold the Annual Meeting on December 30, 2024.
  • The company will announce the results of the votes after the Annual Meeting.

Key Dates

DateDescription
September 1, 2018Effective date of employment agreements with Ronen Luzon, Or Kles, and Billy Pardo.
May 29, 2019Grant date of some options held by named executive officers.
October 8, 2020Grant date of some options held by named executive officers.
September 29, 2022Grant date of restricted share awards to named executive officers.
December 31, 2023End of the fiscal year for which financial statements were reviewed.
February 14, 2024Date of restricted stock unit grants to non-employee directors and restricted stock awards to Ronen Luzon, Or Kles, and Billy Pardo.
April 19, 2024Date of the one-for-eight reverse stock split.
November 4, 2024Record date for determining stockholders eligible to vote at the Annual Meeting and intended date to begin sending notices to stockholders.
December 30, 2024Date of the Annual Meeting of Stockholders.
January 1, 2025Vesting date for restricted stock units granted to non-employee directors on February 14, 2024.
July 7, 2025Deadline for stockholders to submit proposals for inclusion in the 2025 proxy materials.
September 1, 2025Earliest date for submission of director nominations or other business proposals for the 2025 Annual Meeting.
October 1, 2025Latest date for submission of director nominations or other business proposals for the 2025 Annual Meeting.
October 31, 2025Deadline for stockholders intending to solicit proxies in support of director nominees to provide notice.
December 31, 2024Fiscal year end for which Somekh Chaikin is being considered as the independent public accountant.

Keywords

Annual Meeting, Proxy Statement, Stockholders, Director Election, Auditor Ratification, Corporate Governance, My Size, Inc.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.